|
US2013039925A1
|
|
Alternative pathway specific antibodies for treating arthritis
|
|
US2013004485A1
|
|
Humanized and chimeric anti-properdin antibodies
|
|
WO2010096466A2
|
|
Methods and compositions for inhibiting cellular proliferation and surgical adhesion
|
|
US2011160636A1
|
|
Device and method for inhibiting complement activation
|
|
US2010015139A1
|
|
METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Ba SPECIFIC ANTIBODIES AND USE THEREOF
|
|
US2011082126A1
|
|
Method for treating inflammatory conditions
|
|
US2011311532A1
|
|
Inhibition of complement and cellular activation
|
|
US2011195974A1
|
|
Methods of treating inflammatory conditions with adrenergic antagonists
|
|
US2011008340A1
|
|
Anti-properdin antibodies
|
|
US2008233113A1
|
|
Method of inhibiting complement activation with human anti-factor C3 antibodies and use thereof
|
